Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material
Archived releases can be found:
2018
2019
2020
2021
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Ahti Paananen
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Change in BBS-Bioactive Bonesubstitutes Plc’s management
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Oili Halonen
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Jarmo Halonen
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report, 1 January – 30 June 2022 (unaudited)
08.08.2022 Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team
28.06.2022 BBS-Bioactive Bone Substitutes Plc: Trading on BBS’s warrants begins on First North Growth Market Finland
08.06.2022 BBS-Bioactive Bone Substitutes Plc’s rights issue raised gross proceeds of EUR 3.5 million
24.02.2022 Financial Statements Review 1.1.-31.12.2021 (unaudited)
23.02.2022 Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position
11.01.2022 US Patent for the Manufacture of ARTEBONE® product